AIM
NTBL

Acrospire Investment Management’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Acrospire Investment Management’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-79
Closed -$15K – 2599
2017
Q1 		$15K Sell
79
-123
-61% -$23.6K 0.01% 1750
2016
Q4 		$34K Buy
+202
New +$35.1K 0.01% 1590

Other funds holding NTBL

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Acrospire Investment Management's NTBL Position: Q2 2017 in Review

Acrospire Investment Management sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q2 2017, closing a stake of 79 shares — an estimated $15K sold.

Acrospire Investment Management first reported a position in NTBL in Q4 2016 and held it in 2 quarters. The position peaked at $34K in Q4 2016. 26 funds tracked by Wall St. Rank hold NTBL as of Q2 2017.

  • Acrospire Investment Management reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 79 Notable Labs, Ltd. Ordinary Shares shares in Q2 2017, an estimated $15K.
  • Acrospire Investment Management first reported a position in Notable Labs, Ltd. Ordinary Shares in Q4 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Notable Labs, Ltd. Ordinary Shares position peaked at $34K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.